Synthomer Reconfirms 2025 Performance and Advances Debt Refinancing Plan

Synthomer ( (GB:SYNT) ) has provided an update.

Synthomer reconfirmed its 2025 guidance, with continuing revenue of about £1.74bn, EBITDA between £135m and £138m, improved margins and positive free cash flow supported by expanded cost‑reduction measures. The group reported covenant net debt to EBITDA of 4.7‑4.8 times, comfortably within its limit, and year‑to‑date 2026 trading in line with expectations as volume momentum builds despite softer end‑markets and higher raw material and energy costs linked to the conflict in Iran.

Management said it is successfully passing through recent input‑cost inflation via pricing and highlighted that its Middle East joint venture and global supply chains are operating normally, while it targets further progress in 2026 mainly through self‑help actions. The company is in constructive talks with lenders to amend covenants and extend the maturity of key revolving credit and UK Export Finance facilities due in the second half of 2027, and aims to cut leverage through an expanded divestment programme rather than new equity issuance, with largest shareholder KLK reaffirming support and publication of 2025 results pushed to late April 2026 as refinancing continues.

The most recent analyst rating on (GB:SYNT) stock is a Hold with a £51.00 price target. To see the full list of analyst forecasts on Synthomer stock, see the GB:SYNT Stock Forecast page.

Spark’s Take on SYNT Stock

According to Spark, TipRanks’ AI Analyst, SYNT is a Neutral.

Synthomer’s overall stock score reflects significant financial challenges, with negative profitability and high leverage being major concerns. Technical analysis provides mixed signals, with short-term bullish momentum but longer-term bearish trends. Valuation is weak due to a negative P/E ratio. However, positive corporate events, such as insider buying and strategic appointments, offer some optimism for future prospects.

To see Spark’s full report on SYNT stock, click here.

More about Synthomer

Synthomer is a London‑headquartered speciality chemicals group and leading supplier of high‑performance polymers and ingredients used in coatings, construction, adhesives, and health and protection applications. Listed in the UK since 1971, it operates five innovation centres and 29 manufacturing sites across Europe, North America, the Middle East and Asia, serving over 6,000 blue‑chip customers in markets driven by urbanisation, demographic shifts, climate and sustainability trends.

The company’s portfolio spans Coatings & Construction Solutions, Adhesive Solutions, and Health & Protection and Performance Materials, including a world‑leading position in water‑based polymers for medical gloves and major European production of binders, foams and related materials. Around a fifth of sales volumes come from new and patent‑protected products, and Synthomer’s 2030 decarbonisation goals are approved by the Science Based Targets initiative, underpinning its positioning as a green technology player recognised by the London Stock Exchange’s Green Economy Mark.

Average Trading Volume: 1,254,205

Technical Sentiment Signal: Strong Sell

Current Market Cap: £29.44M

For detailed information about SYNT stock, go to TipRanks’ Stock Analysis page.